Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 2
2010 1
2012 1
2017 1
2019 1
2020 2
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Topical cholesterol/lovastatin for the treatment of porokeratosis: A pathogenesis-directed therapy.
Atzmony L, Lim YH, Hamilton C, Leventhal JS, Wagner A, Paller AS, Choate KA. Atzmony L, et al. J Am Acad Dermatol. 2020 Jan;82(1):123-131. doi: 10.1016/j.jaad.2019.08.043. Epub 2019 Aug 23. J Am Acad Dermatol. 2020. PMID: 31449901 Free PMC article.
OBJECTIVE: To study the efficacy of topical cholesterol/lovastatin in different variants of porokeratosis. METHODS: We enrolled a series of 5 porokeratosis patients,1 with disseminated superficial actinic porokeratosis, 2 with porokera
OBJECTIVE: To study the efficacy of topical cholesterol/lovastatin in different variants of porokeratosis. METHODS: We enrolled a ser …
Disseminated superficial actinic porokeratosis: a treatment review.
Skupsky H, Skupsky J, Goldenberg G. Skupsky H, et al. J Dermatolog Treat. 2012 Feb;23(1):52-6. doi: 10.3109/09546634.2010.495381. Epub 2010 Oct 22. J Dermatolog Treat. 2012. PMID: 20964569 Review.
Disseminated superficial actinic porokeratosis (DSAP) is a chronic disorder of keratinization characterized by numerous papules and plaques distributed over sun-exposed sites. ...Herein, we review recent studies pertaining to the treatment of DSAP and
Disseminated superficial actinic porokeratosis (DSAP) is a chronic disorder of keratinization characterized by n
Light and laser treatment modalities for disseminated superficial actinic porokeratosis: a systematic review.
Aird GA, Sitenga JL, Nguyen AH, Vaudreuil A, Huerter CJ. Aird GA, et al. Lasers Med Sci. 2017 May;32(4):945-952. doi: 10.1007/s10103-017-2179-9. Epub 2017 Feb 27. Lasers Med Sci. 2017. PMID: 28239750 Review.
Treatment of disseminated superficial actinic porokeratosis (DSAP) is poorly standardized. ...Laser therapy is a promising treatment option for DSAP with an excellent side effect profile. ...
Treatment of disseminated superficial actinic porokeratosis (DSAP) is poorly standardized. ...Laser therapy
Review of fractional photothermolysis: treatment indications and efficacy.
Tierney EP, Kouba DJ, Hanke CW. Tierney EP, et al. Dermatol Surg. 2009 Oct;35(10):1445-61. doi: 10.1111/j.1524-4725.2009.01258.x. Epub 2009 Jul 20. Dermatol Surg. 2009. PMID: 19686366 Review.
RESULTS: Successful conditions treated with nonablative FP reported in the literature include acne scarring; dyschromia and fine wrinkling of photoaging on the face, chest, neck, and hands; melasma; poikiloderma of Civatte; nevus of Ota; scars; minocycline hyperpigmentation; tela …
RESULTS: Successful conditions treated with nonablative FP reported in the literature include acne scarring; dyschromia and fine wrinkling o …
Treatment of disseminated superficial actinic porokeratosis with topical diclofenac gel: a case series.
Vlachou C, Kanelleas AI, Martin-Clavijo A, Berth-Jones J. Vlachou C, et al. J Eur Acad Dermatol Venereol. 2008 Nov;22(11):1343-5. doi: 10.1111/j.1468-3083.2008.02842.x. Epub 2008 Jun 11. J Eur Acad Dermatol Venereol. 2008. PMID: 18554227
Disseminated superficial actinic porokeratosis (DSAP) is the most common of the of five clinical variants of porokeratosis. ...
Disseminated superficial actinic porokeratosis (DSAP) is the most common of the of five clinical variants of
Diclofenac sodium 3% gel as a potential treatment for disseminated superficial actinic porokeratosis.
Marks S, Varma R, Cantrell W, Chen SC, Gold M, Muellenhoff M, Elewski B. Marks S, et al. J Eur Acad Dermatol Venereol. 2009 Jan;23(1):42-5. doi: 10.1111/j.1468-3083.2008.02943.x. J Eur Acad Dermatol Venereol. 2009. PMID: 18702625
BACKGROUND: Disseminated superficial actinic porokeratosis (DSAP) is a chronic cutaneous disorder of keratinization for which there is no known cure. Current therapies are often ineffective, painful, or unappealing. OBJECTIVE: To investigate the …
BACKGROUND: Disseminated superficial actinic porokeratosis (DSAP) is a chronic cutaneous disorder of keratinizat …
Lichenoid inflammation of DSAP lesions following treatment with durvalumab, olaparib and paclitaxel: A potential diagnostic pitfall mimicking lichenoid drug eruptions associated with PDL-1 inhibitors.
Shakhbazova A, Hinds B, Marsch AF. Shakhbazova A, et al. Dermatol Online J. 2020 Mar 15;26(3):13030/qt7nf6c8hc. Dermatol Online J. 2020. PMID: 32609449 Free article.
Disseminated superficial actinic porokeratosis (DSAP) is an uncommon skin condition that can be inherited or may occur sporadically with multiple red-brown, thin plaques in a photodistribution. The condition more often affects middle-aged women and is
Disseminated superficial actinic porokeratosis (DSAP) is an uncommon skin condition that can be inherited or may